A sorting signal suppresses IFITM1 restriction of viral entry

Journal of Biological Chemistry

Volumn 290, Issue 7, 2015, Pages 4248-4259

  Li, Kun ^a,g   Jia, Rui ^b,h   Li, Minghua ^a   Zheng, Yi Min ^a   Miao, Chunhui ^a   Yao, Yunfang ^b   Ji, Hong Long ^c   Geng, Yunqi ^b   Qiao, Wentao ^b   Albritton, Lorraine M ^d   Liang, Chen ^e,f   Liu, Shan Lu ^a  

^a University of Missouri   (United States)

^b NANKAI UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g UNIVERSITY OF IOWA   (United States)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY;

SORTING SIGNALS; VIRAL INFECTIONS;

BIOLOGY;

ADAPTOR PROTEIN; ALANINE; CD63 ANTIGEN; CYSTEINE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; PROTEIN IFITM1; UNCLASSIFIED DRUG; DIFFERENTIATION ANTIGEN; LEU-13 ANTIGEN; SIGNAL PEPTIDE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; AMPHOTROPHIC MURINE LEUKEMIA VIRUS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE SILENCING; JAAGSIEKTE SHEEP RETROVIRUS; LYSOSOME; MULTIVESICULAR BODY; MURINE LEUKEMIA VIRUS; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; UBIQUITINATION; VIRUS ENTRY; VIRUS PARTICLE; ANIMAL; CELL CULTURE; CELL FUSION; CELL MEMBRANE; GENETICS; HUMAN; IMMUNOPRECIPITATION; METABOLISM; MUTATION; PHYSIOLOGY; PROTEIN TRANSPORT; SHEEP; VIROLOGY; VIRUS INFECTION; VIRUS REPLICATION; WESTERN BLOTTING;

ADAPTOR PROTEIN COMPLEX 3; ANIMALS; ANTIGENS, DIFFERENTIATION; BLOTTING, WESTERN; CELL FUSION; CELL MEMBRANE; CELLS, CULTURED; HUMANS; IMMUNOPRECIPITATION; JAAGSIEKTE SHEEP RETROVIRUS; LYSOSOMES; MUTATION; PROTEIN SORTING SIGNALS; PROTEIN TRANSPORT; SHEEP; VIRUS DISEASES; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84922791416     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.630780     Document Type: Article

References (46)

1. Sadler, A. J., and Williams, B. R. (2008) Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8, 559-568
2. Diamond, M. S., and Farzan, M. (2013) The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 13, 46-57
3. Perreira, J. M., Chin, C. R., Feeley, E. M., and Brass, A. L. (2013) IFITMs restrict the replication of multiple pathogenic viruses. J. Mol. Biol. 425, 4937-4955
4. Siegrist, F., Ebeling, M., and Certa, U. (2011) The small interferon-induced transmembrane genes and proteins. J. Interferon Cytokine Res. 31, 183-197
5. Brass, A. L., Huang, I. C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., Adams, D. J., Xavier, R. J., Farzan, M., and Elledge, S. J. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243-1254
6. Huang, I. C., Bailey, C. C., Weyer, J. L., Radoshitzky, S. R., Becker, M. M., Chiang, J. J., Brass, A. L., Ahmed, A. A., Chi, X., Dong, L., Longobardi, L. E., Boltz, D., Kuhn, J. H., Elledge, S. J., Bavari, S., Denison, M. R., Choe, H., and Farzan, M. (2011) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 7, e1001258
7. Weidner, J. M., Jiang, D., Pan, X. B., Chang, J., Block, T. M., and Guo, J. T. (2010) Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J. Virol. 84, 12646-12657
8. Lu, J., Pan, Q., Rong, L., He, W., Liu, S.-L., and Liang, C. (2011) The IFITM proteins inihibit HIV-1 infection. J. Virol. 85, 2126-2137
9. Chutiwitoonchai, N., Hiyoshi, M., Hiyoshi-Yoshidomi, Y., Hashimoto, M., Tokunaga, K., and Suzu, S. (2013) Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins. Microbes Infect. 15, 280-290
10. Jiang, D., Weidner, J. M., Qing, M., Pan, X. B., Guo, H., Xu, C., Zhang, X., Birk, A., Chang, J., Shi, P. Y., Block, T. M., and Guo, J. T. (2010) Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J. Virol. 84, 8332-8341
11. Li, K., Markosyan, R. M., Zheng, Y.-M., Golfetto, O., Bungart, B., Li, M., Ding, S., Liang, C., He, Y., Lee, J. C., Gratton, E., Cohen, F. S., and Liu, S.-L. (2013) IFITM proteins restrict viral membrane hemifusion. PLoS Pathog. 9, e1003124
12. Mudhasani, R., Tran, J. P., Retterer, C., Radoshitzky, S. R., Kota, K. P., Altamura, L. A., Smith, J. M., Packard, B. Z., Kuhn, J. H., Costantino, J., Garrison, A. R., Schmaljohn, C. S., Huang, I. C., Farzan, M., and Bavari, S. (2013) IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J. Virol. 87, 8451-8464
13. Anafu, A. A., Bowen, C. H., Chin, C. R., Brass, A. L., and Holm, G. H. (2013) Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry. J. Biol. Chem. 288, 17261-17271
14. Everitt, A. R., Clare, S., Pertel, T., John, S. P., Wash, R. S., Smith, S. E., Chin, C. R., Feeley, E. M., Sims, J. S., Adams, D. J., Wise, H. M., Kane, L., Goulding, D., Digard, P., Anttila, V., Baillie, J. K., Walsh, T. S., Hume, D. A., Palotie, A., Xue, Y., Colonna, V., Tyler-Smith, C., Dunning, J., Gordon, S. B., GenISIS Investigators, MOSAIC Investigators, Smyth, R. L., Openshaw, P. J., Dougan, G., Brass, A. L., and Kellam, P. (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519-523
15. Bailey, C. C., Huang, I. C., Kam, C., and Farzan, M. (2012) Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog. 8, e1002909
16. Williams, D. E., Wu, W. L., Grotefend, C. R., Radic, V., Chung, C., Chung, Y. H., Farzan, M., and Huang, I. C. (2014) IFITM3 polymorphism rs12252-C restricts influenza A viruses. PLoS One 9, e110096
17. Mills, T. C., Rautanen, A., Elliott, K. S., Parks, T., Naranbhai, V., Ieven, M. M., Butler, C. C., Little, P., Verheij, T., Garrard, C. S., Hinds, C., Goossens, H., Chapman, S., and Hill, A. V. (2014) IFITM3 and susceptibility to respiratory viral infections in the community. J. Infect. Dis. 209, 1028-1031
18. John, S. P., Chin, C. R., Perreira, J. M., Feeley, E. M., Aker, A. M., Savidis, G., Smith, S. E., Elia, A. E., Everitt, A. R., Vora, M., Pertel, T., Elledge, S. J., Kellam, P., and Brass, A. L. (2013) The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication. J. Virol. 87, 7837-7852
19. Feeley, E. M., Sims, J. S., John, S. P., Chin, C. R., Pertel, T., Chen, L. M., Gaiha, G. D., Ryan, B. J., Donis, R. O., Elledge, S. J., and Brass, A. L. (2011) IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog. 7, e1002337
20. Yount, J. S., Karssemeijer, R. A., and Hang, H. C. (2012) S-Palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J. Biol. Chem. 287, 19631-19641
21. Yount, J. S., Moltedo, B., Yang, Y. Y., Charron, G., Moran, T. M., López, C. B., and Hang, H. C. (2010) Palmitoylome profiling reveals S-palmitoylation- dependent antiviral activity of IFITM3. Nat. Chem. Biol. 6, 610-614
22. Jia, R., Pan, Q., Ding, S., Rong, L., Liu, S.-L., Geng, Y., Qiao, W., and Liang, C. (2012) The N-terminal region of IFITM3 modulates its antiviral activity through regulating IFITM3 cellular location. J. Virol. 86, 13697-13707
23. Amini-Bavil-Olyaee, S., Choi, Y. J., Lee, J. H., Shi, M., Huang, I. C., Farzan, M., and Jung, J. U. (2013) The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 13, 452-464
24. Lin, T. Y., Chin, C. R., Everitt, A. R., Clare, S., Perreira, J. M., Savidis, G., Aker, A. M., John, S. P., Sarlah, D., Carreira, E. M., Elledge, S. J., Kellam, P., and Brass, A. L. (2013) Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction. Cell Rep. 5, 895-908
25. Desai, T. M., Marin, M., Chin, C. R., Savidis, G., Brass, A. L., and Melikyan, G. B. (2014) IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathog. 10, e1004048
26. Bhanja Chowdhury, J., Shrivastava, S., Steele, R., Di Bisceglie, A. M., Ray, R., and Ray, R. B. (2012) Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A. J. Virol. 86, 10221-10225
27. Raychoudhuri, A., Shrivastava, S., Steele, R., Kim, H., Ray, R., and Ray, R. B. (2011) ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J. Virol. 85, 12881-12889
28. Wilkins, C., Woodward, J., Lau, D. T., Barnes, A., Joyce, M., McFarlane, N., McKeating, J. A., Tyrrell, D. L., and Gale, M., Jr. (2013) IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology 57, 461-469
29. Zhao, X., Guo, F., Liu, F., Cuconati, A., Chang, J., Block, T. M., and Guo, J. T. (2014) Interferon induction of IFITM proteins promotes infection by human coronavirus OC43. Proc. Natl. Acad. Sci. U.S.A. 111, 6756-6761
30. Jia, R., Xu, F., Qian, J., Yao, Y., Miao, C., Zheng, Y. M., Liu, S. L., Guo, F., Geng, Y., Qiao, W., and Liang, C. (2014) Identification of an endocytic signal essential for the antiviral action of IFITM3. Cell Microbiol. 16, 1080-1093
31. Côté, M., Zheng, Y. M., Albritton, L. M., and Liu, S.-L. (2008) Fusogenicity of Jaagsiekte sheep retrovirus envelope protein is dependent on low pH and is enhanced by cytoplasmic tail truncations. J. Virol. 82, 2543-2554
32. Janaka, S. K., Gregory, D. A., and Johnson, M. C. (2013) Retrovirus glycoprotein functionality requires proper alignment of the ectodomain and the membrane proximal cytoplasmic tail. J. Virol. 87, 12805-12813
33. Côté, M., Zheng, Y. M., Li, K., Xiang, S.-H., Albritton, L. M., and Liu, S.-L. (2012) Critical role of a leucine-valine change in the distinct low pH requirements for membrane fusion between two related retrovirus envelope. J. Biol. Chem. 287, 7640-7651
34. Zhou, H., Ferraro, D., Zhao, J., Hussain, S., Shao, J., Trujillo, J., Netland, J., Gallagher, T., and Perlman, S. (2010) The N-terminal region of severe acute respiratory syndrome coronavirus protein 6 induces membrane rearrangement and enhances virus replication. J. Virol. 84, 3542-3551
35. Côté, M., Kucharski, T. J., and Liu, S.-L. (2008) Enzootic nasal tumor virus envelope requires a very acidic pH for fusion activation and infection. J. Virol. 82, 9023-9034
36. Bertrand, P., Côté, M., Zheng, Y. M., Albritton, L. M., and Liu, S.-L. (2008) Jaagsiekte sheep retrovirus utilizes a pH-dependent endocytosis pathway for entry. J. Virol. 82, 2555-2559
37. Bonifacino, J. S., and Traub, L. M. (2003) Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu. Rev. Biochem. 72, 395-447
38. Hirst, J., Barlow, L. D., Francisco, G. C., Sahlender, D. A., Seaman, M. N., Dacks, J. B., and Robinson, M. S. (2011) The fifth adaptor protein complex. PLoS Biol. 9, e1001170
39. Bogdanov, M., Heacock, P. N., and Dowhan, W. (2010) Study of polytopic membrane protein topological organization as a function of membrane lipid composition. Methods Mol. Biol. 619, 79-101
40. Marsh, M., and Helenius, A. (2006) Virus entry: open sesame. Cell 124, 729-740
41. Beer, C., Andersen, D. S., Rojek, A., and Pedersen, L. (2005) Caveola-dependent endocytic entry of amphotropic murine leukemia virus. J. Virol. 79, 10776-10787
42. Kreis, T. E., Lowe, M., and Pepperkok, R. (1995) COPs regulating membrane traffic. Annu. Rev. Cell Dev. Biol. 11, 677-706
43. Ma, W., and Goldberg, J. (2013) Rules for the recognition of dilysine retrieval motifs by coatomer. EMBO J. 32, 926-937
44. Jackson, L. P., Lewis, M., Kent, H. M., Edeling, M. A., Evans, P. R., Duden, R., and Owen, D. J. (2012) Molecular basis for recognition of dilysine trafficking motifs by COPI. Dev. Cell 23, 1255-1262
45. Bailey, C. C., Kondur, H. R., Huang, I. C., and Farzan, M. (2013) Interferoninduced transmembrane protein 3 is a type II transmembrane protein. J. Biol. Chem. 288, 32184-32193
46. Weston, S., Czieso, S., White, I. J., Smith, S. E., Kellam, P., and Marsh, M. (2014) A membrane topology model for human interferon inducible transmembrane protein 1. PLoS One 9, e104341